Skip to main content
Premium Trial:

Request an Annual Quote

Bayer CropScience, Evogene Ink Alliance

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Bayer CropScience and Evogene today announced that they have entered into a five-year genomics research alliance aimed at accelerating the development and introduction of improved wheat varieties.

The firms will use Evogene's Athlete, RePack, and EvoBreed computational genomic technologies to identify genetically modified and native traits to improve yield, drought tolerance, fertilizer utilization, and other characteristics. The collaboration builds on an earlier alliance between the firms focused on increasing rice productivity and yield.

Rehovot, Israel-based Evogene will receive around $20 million in upfront fees and annual research payments over the term of the agreement. In addition, it will receive development milestone payments and royalties on the commercialization of any resulting products. Further details of the agreement were not disclosed.

Bayer CropScience also will make an equity investment of $12 million in Evogene at a price of approximately $7 per ordinary share.

The Scan

Harvard Team Report One-Time Base Editing Treatment for Motor Neuron Disease in Mice

A base-editing approach restored SMN levels and improved motor function in a mouse model of spinal muscular atrophy, a new Science paper reports.

International Team Examines History of North American Horses

Genetic and other analyses presented in Science find that horses spread to the northern Rockies and Great Plains by the first half of the 17th century.

New Study Examines Genetic Dominance Within UK Biobank

Researchers analyze instances of genetic dominance within UK Biobank data, as they report in Science.

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.